US Tech 100

19,162.80

-0.06%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
ETFs
USA
AMEX
Meet Kevin Pricing Power ETF (PP)
Meet Kevin Pricing Power ETF (PP) News

PP

Meet Kevin Pricing Power... (PP)

Meet Kevin Pricing Power ETF

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:PP

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
10/09/2008	12:03PM	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	AMEX:PP	Meet Kevin Pricing Power ETF
10/06/2008	7:30AM	Marketwired	Pipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7th	AMEX:PP	Meet Kevin Pricing Power ETF
09/19/2008	7:30AM	Marketwired	Pipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and Re	AMEX:PP	Meet Kevin Pricing Power ETF
08/29/2008	4:01PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A)	AMEX:PP	Meet Kevin Pricing Power ETF
08/19/2008	7:54AM	Marketwired	Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis	AMEX:PP	Meet Kevin Pricing Power ETF
08/19/2008	7:30AM	Marketwired	Pipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York City	AMEX:PP	Meet Kevin Pricing Power ETF
08/14/2008	3:49PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)	AMEX:PP	Meet Kevin Pricing Power ETF
08/14/2008	3:18PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
08/14/2008	12:39PM	Marketwired	Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results	AMEX:PP	Meet Kevin Pricing Power ETF
08/12/2008	7:27AM	Marketwired	Pipex Pharmaceuticals to Present at the Noble Financial Equity Conference	AMEX:PP	Meet Kevin Pricing Power ETF
07/15/2008	7:40AM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:PP	Meet Kevin Pricing Power ETF
07/14/2008	5:45PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:PP	Meet Kevin Pricing Power ETF
07/09/2008	1:48PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
07/09/2008	7:38AM	Marketwired	Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Or	AMEX:PP	Meet Kevin Pricing Power ETF
07/08/2008	4:16PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
07/08/2008	2:54PM	Marketwired	Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in Dry	AMEX:PP	Meet Kevin Pricing Power ETF
07/08/2008	6:41AM	Marketwired	Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer	AMEX:PP	Meet Kevin Pricing Power ETF
05/20/2008	8:00AM	Marketwired	Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules	AMEX:PP	Meet Kevin Pricing Power ETF
05/16/2008	9:59AM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
05/15/2008	4:13PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)	AMEX:PP	Meet Kevin Pricing Power ETF
05/15/2008	3:36PM	Marketwired	Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results	AMEX:PP	Meet Kevin Pricing Power ETF
05/13/2008	8:05AM	Marketwired	Pipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15	AMEX:PP	Meet Kevin Pricing Power ETF
05/12/2008	8:23AM	Marketwired	Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)	AMEX:PP	Meet Kevin Pricing Power ETF
05/07/2008	8:00AM	Marketwired	Pipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's Disease	AMEX:PP	Meet Kevin Pricing Power ETF
05/02/2008	7:38AM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
04/29/2008	2:35PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A)	AMEX:PP	Meet Kevin Pricing Power ETF
04/21/2008	7:02AM	Marketwired	Pipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for Fibromyalgia	AMEX:PP	Meet Kevin Pricing Power ETF
04/18/2008	4:13PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	AMEX:PP	Meet Kevin Pricing Power ETF
04/15/2008	10:12AM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:PP	Meet Kevin Pricing Power ETF
04/01/2008	12:49PM	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF